Effects of two oral doses of alendronate in the treatment of Paget's disease of bone.

Abstract:

:Twenty patients with mild Paget's disease of bone were given either 20 (10 patients) or 40 mg alendronate daily for 6 months. The 20-mg dose was well tolerated, but in 3 patients on 40 mg/d alendronate, the treatment was withdrawn after 3-5 months because of gastric and oesophageal disturbances. Urinary hydroxyproline excretion fell within the first month to 77 +/- 5% (SD) and to 47 +/- 5% of pretreatment values in the 20- and 40-mg dosing group, respectively (p < 0.001 between group comparison). The serum alkaline phosphatase fell more slowly with the maximum suppression of disease activity reached at 4 months, when it attained a plateau in both groups of patients. However, the decrease in serum alkaline phosphatase was significantly more pronounced in the patients treated with 40 mg/d tablets (50 +/- 10% of pretreatment values) than in those given 20 mg alendronate per day (76 +/- 9% of initial value), in none of whom a disease remission was observed. It appears, therefore, that while 20 mg/d oral doses of alendronate are insufficient, 40 mg/d are associated with a high incidence of side effects. Furthermore, the suppression of disease activity depends on the dose of bisphosphonate given daily or over a short period of time and lower doses cannot be compensated by a longer duration of the treatment course.

journal_name

Bone

journal_title

Bone

authors

Adami S,Mian M,Gatti P,Rossini M,Zamberlan N,Bertoldo F,Lo Cascio V

doi

10.1016/8756-3282(94)90818-4

subject

Has Abstract

pub_date

1994-07-01 00:00:00

pages

415-7

issue

4

eissn

8756-3282

issn

1873-2763

pii

8756-3282(94)90818-4

journal_volume

15

pub_type

临床试验,杂志文章

相关文献

BONE文献大全
  • Deletion of FOXO1 in chondrocytes rescues the effect of diabetes on mechanical strength in fracture healing.

    abstract::Diabetes increases the risk of fracture, impairs fracture healing and causes rapid loss of the fracture callus cartilage, which was linked to increased FOXO1 expression in chondrocytes. We recently demonstrated that deletion of FOXO1 in chondrocytes blocked the premature removal of cartilage associated with endochondr...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.03.026

    authors: Lu Y,Alharbi M,Zhang C,O'Connor JP,Graves DT

    更新日期:2019-06-01 00:00:00

  • Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation.

    abstract::In the present study, we investigate the implication of the mitogen-activated protein kinases (MAPKs) Erk, p38, and JNK in mediating the effect of fetal calf serum (FCS) on the differentiation of MC3T3-E1 osteoblast-like cells. Erk is stimulated by FCS in proliferating, early-differentiating, as well as in mature cell...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(01)00660-3

    authors: Suzuki A,Guicheux J,Palmer G,Miura Y,Oiso Y,Bonjour JP,Caverzasio J

    更新日期:2002-01-01 00:00:00

  • Effects of experimental conditions on the release of 45calcium from prelabeled fetal mouse long bones.

    abstract::Embryonic/neonatal bones in culture are commonly used for the study of osteoclastic resorption in vitro. For this purpose, the release of 45calcium (45Ca) from prelabeled bones is measured as an index of resorption. We studied 45Ca release from two types of long bone explants after different preparation methods: 17-da...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(95)00135-z

    authors: van Beek E,Oostendorp-van de Ruit M,van der Wee-Pals L,Bloys H,van de Bent C,Papapoulos S,Löwik C

    更新日期:1995-07-01 00:00:00

  • Ameloblastin modulates osteoclastogenesis through the integrin/ERK pathway.

    abstract::Proteins of the extracellular matrix often have multiple functions to facilitate complex tasks ranging from signaling to structural support. Here we have focused on the function of one of the matrix proteins expressed in bones and teeth, the matrix adhesion protein ameloblastin (AMBN). Transgenic mice with 5-fold elev...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2013.01.041

    authors: Lu X,Ito Y,Atsawasuwan P,Dangaria S,Yan X,Wu T,Evans CA,Luan X

    更新日期:2013-05-01 00:00:00

  • Effect of combined treatment with zoledronic acid and parathyroid hormone on mouse bone callus structure and composition.

    abstract::In recent years, great interest in combined treatment of parathyroid hormone (PTH) with anti-resorptive therapy has emerged. PTH has been suggested to aid bridging of atrophic fractures and improve strength in closed fracture models. Bisphosphonate treatments typically result in a larger woven bone callus that is slow...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2016.08.012

    authors: Casanova M,Herelle J,Thomas M,Softley R,Schindeler A,Little D,Schneider P,Müller R

    更新日期:2016-11-01 00:00:00

  • Bone and cancer: pathophysiology and treatment of metastases.

    abstract::The variability of different primary tumors in the susceptibility to metastatic bone disease is poorly understood. Factors that determine the viability of metastatic cells are also poorly understood, but may depend in part upon gene expression of PTHrP and the vitamin D receptor. In contrast, much more is known of the...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/8756-3282(95)00194-i

    authors: Kanis JA

    更新日期:1995-08-01 00:00:00

  • Adiponectin as a novel determinant of bone mineral density and visceral fat.

    abstract::Growing evidence suggests that positive associations between fat mass (FM) and bone mineral density (BMD) are mediated by not only biomechanical but also biochemical factors. Adiponectin is a novel adipocyte-derived hormone that regulates energy homeostasis and has anti-inflammatory and anti-atherogenic effects. Unlik...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(03)00237-0

    authors: Lenchik L,Register TC,Hsu FC,Lohman K,Nicklas BJ,Freedman BI,Langefeld CD,Carr JJ,Bowden DW

    更新日期:2003-10-01 00:00:00

  • Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat model.

    abstract:INTRODUCTION:While the anti-resorptive effects of the bisphosphonates (BPs) are well documented, many questions remain about their mechanisms of action, particularly following long-term use. This study evaluated the effects of alendronate (Ale) treatment on TGF-β1 signaling in mesenchymal stem cells (MSCs) and osteocyt...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.10.017

    authors: Jia J,Yao W,Amugongo S,Shahnazari M,Dai W,Lay YA,Olvera D,Zimmermann EA,Ritchie RO,Li CS,Alliston T,Lane NE

    更新日期:2013-01-01 00:00:00

  • Runx2 is required for early stages of endochondral bone formation but delays final stages of bone repair in Axin2-deficient mice.

    abstract::Runx2 and Axin2 regulate skeletal development. We recently determined that Axin2 and Runx2 molecularly interact in differentiating osteoblasts to regulate intramembranous bone formation, but the relationship between these factors in endochondral bone formation was unresolved. To address this, we examined the effects o...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.06.022

    authors: McGee-Lawrence ME,Carpio LR,Bradley EW,Dudakovic A,Lian JB,van Wijnen AJ,Kakar S,Hsu W,Westendorf JJ

    更新日期:2014-09-01 00:00:00

  • Dexamethasone inhibits and thyroid hormone promotes differentiation of mouse chondrogenic ATDC5 cells.

    abstract::The effects of glucocorticoid (GC) excess, thyrotoxicosis, and hypothyroidism on linear growth indicate that growth plate chondrocytes are exquisitely sensitive to GC and thyroid hormone (T(3)). Murine ATDC5 cells undergo chondrogenesis in vitro and were used to evaluate the effects of dexamethasone (Dex) and T(3) on ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(02)00855-4

    authors: Siebler T,Robson H,Shalet SM,Williams GR

    更新日期:2002-10-01 00:00:00

  • Inhibition of osteoclasts differentiation by CDC2-induced NFATc1 phosphorylation.

    abstract::Bone homeostasis is regulated by a balance of bone formation and bone resorption; dysregulation of bone homeostasis may cause bone-related diseases (e.g., osteoporosis, osteopetrosis, bone fracture). Members of the nuclear factor of activated T cells (NFAT) family of transcription factors play crucial roles in the reg...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.115153

    authors: Kim HM,He L,Lee S,Park C,Kim DH,Han HJ,Han J,Hwang J,Cha-Molstad H,Lee KH,Ko SK,Jang JH,Ryoo IJ,Blenis J,Lee HG,Ahn JS,Kwon YT,Soung NK,Kim BY

    更新日期:2020-02-01 00:00:00

  • Phenotyping and genotyping of skeletal dysplasias: Evolution of a center and a decade of experience in India.

    abstract::Genetic heterogeneity, high burden and the paucity of genetic testing for rare diseases challenge genomic healthcare for these disorders in India. Here we report our experience over the past decade, of establishing the genomic evaluation of skeletal dysplasia at a tertiary university hospital in India. Research or cli...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2018.10.026

    authors: Uttarilli A,Shah H,Bhavani GS,Upadhyai P,Shukla A,Girisha KM

    更新日期:2019-03-01 00:00:00

  • Exercise-induced changes in the cortical bone of growing mice are bone- and gender-specific.

    abstract::Fracture risk and mechanical competence of bone are functions of bone mass and tissue quality, which in turn are dependent on the bone's mechanical environment. Male mice have a greater response to non-weight-bearing exercise than females, resulting in larger, stronger bones compared with control animals. The aim of t...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2006.12.002

    authors: Wallace JM,Rajachar RM,Allen MR,Bloomfield SA,Robey PG,Young MF,Kohn DH

    更新日期:2007-04-01 00:00:00

  • Differential turnover of cortical and trabecular bone in transgenic mice overexpressing cathepsin K.

    abstract::Cathepsin K is a major osteoclastic protease. We have recently shown that overexpression of mouse cathepsin K gene in transgenic UTU17 mouse model results in high turnover osteopenia of metaphyseal trabecular bone at the age of 7 months. The present report extends these studies to a systematic analysis of cortical bon...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2005.02.006

    authors: Morko J,Kiviranta R,Hurme S,Rantakokko J,Vuorio E

    更新日期:2005-05-01 00:00:00

  • Prevalence of rickets-like bone deformities in rural Gambian children.

    abstract::The aim of this study was to estimate the burden of childhood rickets-like bone deformity in a rural region of West Africa where rickets has been reported in association with a low calcium intake. A population-based survey of children aged 0.5-17.9 years living in the province of West Kiang, The Gambia was conducted i...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2015.04.011

    authors: Jones HL,Jammeh L,Owens S,Fulford AJ,Moore SE,Pettifor JM,Prentice A

    更新日期:2015-08-01 00:00:00

  • Demethylation of ITGAV accelerates osteogenic differentiation in a blast-induced heterotopic ossification in vitro cell culture model.

    abstract::Trauma-induced heterotopic ossification is an intriguing phenomenon involving the inappropriate ossification of soft tissues within the body such as the muscle and ligaments. This inappropriate formation of bone is highly prevalent in those affected by blast injuries. Here, we developed a simplified cell culture model...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2018.09.008

    authors: Logan NJ,Camman M,Williams G,Higgins CA

    更新日期:2018-12-01 00:00:00

  • Ectopic bone formation in severely combat-injured orthopedic patients -- a hematopoietic niche.

    abstract::Combat-related heterotopic ossification (HO) has emerged as a common and problematic complication of modern wartime extremity injuries, contributing to substantial patient morbidity and loss of function. We have previously reported that HO-forming patients exhibit a more pronounced systemic and local inflammatory resp...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2013.05.016

    authors: Davis TA,Lazdun Y,Potter BK,Forsberg JA

    更新日期:2013-09-01 00:00:00

  • Role of cytokines in bone resorption.

    abstract::It has been established during the past few years that interleukin(s)-1, -6, -11 (IL-1, IL-6, IL-11), and tumor necrosis factor (TNF) can stimulate osteoclast development and thereby the process of bone resorption. Moreover, upregulation of the production and/or action of IL-6 has been implicated in the pathogenesis o...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/8756-3282(95)00180-l

    authors: Manolagas SC

    更新日期:1995-08-01 00:00:00

  • Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation.

    abstract::Interleukin-1 (IL-1) has been shown to promote osteoclast (OC) differentiation, in addition to acting as a survival factor for mature osteoclasts. In this study, we investigate the expression of IL-1 during human osteoclast formation, taking advantage of a recently reported in vitro culture system that generates human...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(99)00176-3

    authors: Haynes DR,Atkins GJ,Loric M,Crotti TN,Geary SM,Findlay DM

    更新日期:1999-09-01 00:00:00

  • The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: findings from a pQCT case-control study.

    abstract::High bone mass (HBM), detected in 0.2% of DXA scans, is characterised by a mild skeletal dysplasia largely unexplained by known genetic mutations. We conducted the first systematic assessment of the skeletal phenotype in unexplained HBM using pQCT in our unique HBM population identified from screening routine UK NHS D...

    journal_title:Bone

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.bone.2012.10.021

    authors: Gregson CL,Sayers A,Lazar V,Steel S,Dennison EM,Cooper C,Smith GD,Rittweger J,Tobias JH

    更新日期:2013-01-01 00:00:00

  • Determinants of bone gamma-carboxyglutamic acid-containing protein in plasma of healthy aging subjects.

    abstract::The gamma-carboxy glutamic acid (Gla)-containing protein of mammalian bone (BGP, also called osteocalcin) is a 49 amino acid polypeptide containing two to three residues of gamma-carboxyglutamic acid. BGP is synthesized by osteoblastlike cells, and plasma BGP in laboratory animals is derived principally from recently ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(85)90400-4

    authors: Catherwood BD,Marcus R,Madvig P,Cheung AK

    更新日期:1985-01-01 00:00:00

  • Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series.

    abstract::Progressive osseous heteroplasia (POH) is a rare autosomal dominant disorder of mesenchymal differentiation characterized by progressive heterotopic ossification (HO) of dermis, deep connective tissues and skeletal muscle. Usually, initial bone formation occurs during infancy as primary osteoma cutis (OC) then progres...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2013.06.015

    authors: Elli FM,Barbieri AM,Bordogna P,Ferrari P,Bufo R,Ferrante E,Giardino E,Beck-Peccoz P,Spada A,Mantovani G

    更新日期:2013-10-01 00:00:00

  • The Sox2 high mobility group transcription factor inhibits mature osteoblast function in transgenic mice.

    abstract::We have previously shown that in osteoblasts Sox2 expression can be induced by Fgfs, and can inhibit Wnt signaling and differentiation. Furthermore, in mice in which Sox2 is conditionally deleted in the osteoblastic lineage, bones are osteopenic, and Sox2 inactivation in cultured osteoblasts leads to a loss of prolife...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2011.06.008

    authors: Holmes G,Bromage TG,Basilico C

    更新日期:2011-10-01 00:00:00

  • Ultrashort echo time magnetic resonance imaging (UTE-MRI) of cortical bone correlates well with histomorphometric assessment of bone microstructure.

    abstract::Ultrashort echo time magnetic resonance imaging (UTE-MRI) techniques have been increasingly used to assess cortical bone microstructure. High resolution micro computed tomography (μCT) is routinely employed for validating the MRI-based assessments. However, water protons in cortical bone may reside in micropores small...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.03.013

    authors: Jerban S,Ma Y,Wong JH,Nazaran A,Searleman A,Wan L,Williams J,Du J,Chang EY

    更新日期:2019-06-01 00:00:00

  • Raman spectroscopic analysis of combat-related heterotopic ossification development.

    abstract::Over 60% of our severely combat-injured patient population develops radiographically apparent heterotopic ossification. Nearly a third of these require surgical excision of symptomatic lesions, a procedure that is fraught with complications, and delays or regresses functional rehabilitation in many cases. Unfortunatel...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2013.08.026

    authors: Crane NJ,Polfer E,Elster EA,Potter BK,Forsberg JA

    更新日期:2013-12-01 00:00:00

  • Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.

    abstract::Alendronate has been shown to reduce bone turnover and increase bone mass. However, little is known about the duration of the effect on bone after treatment withdrawal. The aim of this study was to investigate the long-term effects on bone mineral density (BMD) and bone turnover of various alendronate regimens after t...

    journal_title:Bone

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s8756-3282(03)00112-1

    authors: Bagger YZ,Tankó LB,Alexandersen P,Ravn P,Christiansen C

    更新日期:2003-09-01 00:00:00

  • Assessing bone quantity by pQCT.

    abstract::We have tested the ability of the XCT960A to detect bone loss in OVX-rats, as well as bone gain in the proximal tibial metaphysis of healthy rats treated with hPTH(1-34). The results demonstrated that high precision can be achieved, with CV's for most measurement parameters in the range of 1.6 to 5.9% being obtained i...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(95)00287-n

    authors: Gasser JA

    更新日期:1995-10-01 00:00:00

  • Growth of new bone guided by implants in a murine calvarial model.

    abstract::New methods to increase vertical bone growth are needed to permit dental implant placement in patients with low alveolar ridge height after extended periods of tooth loss. While ectopic rodent models are typically used to evaluate new osteogenic implant surface coatings, a more relevant intramembraneous rodent model w...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2008.05.021

    authors: Freilich M,M Patel C,Wei M,Shafer D,Schleier P,Hortschansky P,Kompali R,Kuhn L

    更新日期:2008-10-01 00:00:00

  • Tetracycline/flurbiprofen combination therapy modulates bone remodeling in ovariectomized rats: preliminary observations.

    abstract::The loss of trabecular bone in the ovariectomized (OVX) rat provides a useful experimental model of postmenopausal osteoporosis. In this study, two bone-modulating compounds, an NSAID (flurbiprofen: FBP) and a chemically modified nonantimicrobial tetracycline (CMT), were tested either individually or in combination in...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(96)00280-3

    authors: Aoyagi M,Sasaki T,Ramamurthy NS,Golub LM

    更新日期:1996-12-01 00:00:00

  • Determinants of bone density and prevalence of osteopenia among female runners in their second to seventh decades of age.

    abstract::This is a cross-sectional study of spine and hip bone density (BMD) in 124 female athletes, aged 16-68 years, who trained for at least 3 hs/week. The aim was to document the effects of competitive running on BMD in women over a broad age range. Thirty-three subjects, aged <35 years, were currently oligo- or amenorrhei...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(00)00274-x

    authors: Gibson JH,Harries M,Mitchell A,Godfrey R,Lunt M,Reeve J

    更新日期:2000-06-01 00:00:00